"N Engl J Med"[journal] 检索结果

101. Abdominojugular Reflux Test.

作者: Stephen Bent.;Gurpreet Dhaliwal.
来源: N Engl J Med. 2025年393卷8期e10页

102. Educational Strategies for Clinical Supervision of Artificial Intelligence Use.

作者: Raja-Elie E Abdulnour.;Brian Gin.;Christy K Boscardin.
来源: N Engl J Med. 2025年393卷8期786-797页

103. Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis.

作者: Bruce C Trapnell.;Yoshikazu Inoue.;Francesco Bonella.;Tisha Wang.;Cormac McCarthy.;Toru Arai.;Keiichi Akasaka.;Francesca Mariani.;Nesrin Mogulkoc.;Jin Woo Song.;Tomohisa Baba.;Stephane Jouneau.;Tadahisa Numakura.;Nesrin Öcal.;Florin Mihaltan.;Ali Ataya.;Elisabeth Bendstrup.;Ilaria Campo.;Brenna Carey.;Ross Arena.;Brian Robinson.;Rosanna Fleming.;Yasmine Wasfi.;Raymond Pratt.; .
来源: N Engl J Med. 2025年393卷8期764-773页

Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare disease characterized by progressive surfactant accumulation and hypoxemia caused by autoantibodies against granulocyte-macrophage colony-stimulating factor (GM-CSF), which alveolar macrophages require to clear surfactant. Molgramostim is a formulation of inhaled recombinant human GM-CSF, but its efficacy and safety in patients with aPAP have not been studied sufficiently.

104. Cancer of Unknown Primary Site. Reply.

作者: Kanwal Raghav.
来源: N Engl J Med. 2025年393卷7期728页

105. Cancer of Unknown Primary Site.

作者: Joseph A Bellanti.;Dongmei Li.
来源: N Engl J Med. 2025年393卷7期727-728页

106. Cancer of Unknown Primary Site.

作者: Michele Bibas.
来源: N Engl J Med. 2025年393卷7期727页

107. Lorundrostat Efficacy and Safety in Uncontrolled Hypertension. Reply.

作者: Luke J Laffin.;David Rodman.;Steven E Nissen.
来源: N Engl J Med. 2025年393卷7期726-727页

108. Lorundrostat Efficacy and Safety in Uncontrolled Hypertension.

作者: James M Pollock.
来源: N Engl J Med. 2025年393卷7期726页

109. Lorundrostat Efficacy and Safety in Uncontrolled Hypertension.

作者: Elena Burgos.;Beatriz Fernández Fernández.;Alberto Ortiz.
来源: N Engl J Med. 2025年393卷7期725-726页

110. Oral Semaglutide and Cardiovascular Outcomes. Reply.

作者: Darren K McGuire.;Jens-Peter David.;Silvio E Inzucchi.
来源: N Engl J Med. 2025年393卷7期725页

111. Oral Semaglutide and Cardiovascular Outcomes.

作者: Marcel Catão F Dos Santos.;Natália Nóbrega de Lima.;Josivan G Lima.
来源: N Engl J Med. 2025年393卷7期724-725页

112. A Naturally Occurring Gain-of-Function Mutation in Factor VIII.

作者: Joshua T Wischmeyer.;Christine H Baird.;Julian Grandvallet Contreras.;Alexander Tran.;Tzu Phang.;Tian Liu.;Marilyn J Manco-Johnson.
来源: N Engl J Med. 2025年393卷7期722-724页

113. Managing Obesity.

作者: Christos P Kotanidis.;A Michael Lincoff.;Scott A Shikora.
来源: N Engl J Med. 2025年393卷7期719-721页

114. Presymptomatic Treatment of a Genetic Disease with a Small-Molecule Drug.

作者: Charlotte J Sumner.
来源: N Engl J Med. 2025年393卷7期714-717页

115. Expanding the Treat-to-Target Toolbox for Obesity and Diabetes Care.

作者: Craig M Hales.
来源: N Engl J Med. 2025年393卷7期712-714页

116. Case 23-2025: A 28-Year-Old Woman with Respiratory Failure and Abnormal Chest Imaging.

作者: William J Janssen.;Zachary Hartley-Blossom.;Noah C Schoenberg.;Mark F Sabbagh.
来源: N Engl J Med. 2025年393卷7期700-710页

117. Snowman Sign in Pituitary Macroadenoma.

作者: Yuwei Zhou.;Wei Weng.
来源: N Engl J Med. 2025年393卷7期699页

118. Metabolic Dysfunction-Associated Steatotic Liver Disease.

作者: Giovanni Targher.;Luca Valenti.;Christopher D Byrne.
来源: N Engl J Med. 2025年393卷7期683-698页

119. Risdiplam in Presymptomatic Spinal Muscular Atrophy.

作者: Richard S Finkel.;Laurent Servais.;Dmitry Vlodavets.;Edmar Zanoteli.;Maria Mazurkiewicz-Bełdzińska.;Yuh-Jyh Jong.;Aledie Navas-Nazario.;Mohammad Al-Muhaizea.;Alexandra P Q C Araujo.;Leslie Nelson.;Yi Wang.;Birgit Jaber.;Ksenija Gorni.;Heidemarie Kletzl.;Laura Palfreeman.;Michael Rabbia.;Dave Summers.;Eleni Gaki.;Kathryn R Wagner.;Paulo Fontoura.;Michelle A Farrar.;Enrico Bertini.; .
来源: N Engl J Med. 2025年393卷7期671-682页

Risdiplam, an oral pre-messenger RNA splicing modifier, is an efficacious treatment for persons with symptomatic spinal muscular atrophy (SMA). The safety and efficacy of risdiplam in presymptomatic disease are unclear.

120. The Resurgence of Private Law in American Health Care.

作者: Christopher Robertson.;Wendy N Epstein.
来源: N Engl J Med. 2025年393卷7期630-631页

结果排序

文献格式

出版时间

出版类型

出版语言